Role of Brachytherapy Boost in Clinically Localized Intermediate and High-Risk Prostate Cancer: Lack of Benefit in Patients with Very High-Risk Factors T3b–4 and/or Gleason 9–10

This study examined the role of brachytherapy boost (BT-boost) and external beam radiotherapy (EBRT) in intermediate- to high-risk prostate cancer, especially in patients with very high-risk factors (VHR: T3b–4 or Gleason score 9–10) as patients with double very high-risk factors (VHR-2: T3b–4 and G...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancers 2022-06, Vol.14 (12), p.2976
Hauptverfasser:	Yamazaki, Hideya, Suzuki, Gen, Masui, Koji, Aibe, Norihiro, Shimizu, Daisuke, Kimoto, Takuya, Yamada, Kei, Okihara, Koji, Ueda, Takashi, Narukawa, Tsukasa, Shiraishi, Takumi, Fujihara, Atsuko, Yoshida, Ken, Nakamura, Satoaki, Kato, Takashi, Hashimoto, Yasutoshi, Okabe, Haruumi
Format:	Artikel
Sprache:	eng
Schlagworte:	Brachytherapy Classification Clinical trials Hospitals Metastasis Open data Patients Prognosis Prostate cancer Prostate-specific antigen Radiation therapy Risk factors Risk groups Survival
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!